Prevention by cromakalim of spontaneously occurring cardiac necroses in polymyopathic hamsters

Cardiovascular Drugs and Therapy
G Jasmin, L Proschek

Abstract

Previous studies on the heart necrotizing process at early stages of the hamster polymyopathy have led us to believe that this hereditary disease derives from a defective transmembrane ion flux resulting in myocardial Ca2+ over-load. On the other hand, certain K+ ATP channel openers were shown to prevent cytosolic Ca2+ accumulation in ischemic hearts. Therefore, we investigated the potential beneficial effect of chronic treatment with cromakalim (CR) on the development of necrotic changes in hamster myopathic hearts. Young cardiomyopathic (CM) hamsters were treated parenterally with CR over 4 consecutive weeks. The K+ ATP opener was dissolved in 5% DMSO and injected twice daily (s.c. and i.p. alternatively) at a dose level of 2.5 mg/kg per injection. Microscopic readings were carried out in staged serial paraffin sections of heart ventricles, the diaphragm, and tongue, will all tissues freshly taken at autopsy. In comparison with control untreated hearts, which exhibit numerous necrotic calcific foci, only minute myolytic lesions were found in 5 of 12 hamsters hearts receiving CR (p < 0.0001). Interestingly, the dystrophic process in the tongue was significantly less severe (p < 0.0004) in CR-treated animals. These observations...Continue Reading

References

Jan 1, 1992·Fundamental & Clinical Pharmacology·U Quast
Jul 1, 1992·Trends in Pharmacological Sciences·D Escande, I Cavero
Aug 1, 1991·Clinical Science·S KajiokaH Kuriyama
Jan 1, 1989·Pflügers Archiv : European journal of physiology·E Carmeliet
Mar 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·A SpulerP Grafe
Jan 1, 1989·Pflügers Archiv : European journal of physiology·S QuasthoffP Grafe
Jan 1, 1970·European Neurology·H P Ludin
Jul 1, 1983·Muscle & Nerve·G Jasmin, L Proschek
Mar 1, 1995·Cardiovascular Drugs and Therapy·I CaveroJ M Guillon
Mar 1, 1994·Journal of Molecular and Cellular Cardiology·J L Sapp, S E Howlett
Aug 1, 1993·Cardiovascular Drugs and Therapy·L H Opie
Feb 1, 1961·Acta Physiologica Scandinavica·U von EULER, F LISHAJKO

❮ Previous
Next ❯

Citations

Jan 26, 2006·Alcoholism, Clinical and Experimental Research·Naima CorovićMarjeta Misigoj-Duraković
Apr 25, 2003·Canadian Journal of Physiology and Pharmacology·Danielle JacquesMirna Chahine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.